Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search
  1. NCI-F Publications

Search
  1. Year Published:

Your search returned 56 results.
User Information
Export Records
  1. 1.   Immune cell phenotype and function patterns across the life course in individuals from rural Uganda
  2. Nalwoga, Angela; Nakibuule, Marjorie; Roshan,Romin; Kwizera Mbonye, Moses; Miley,Wendell; Whitby,Denise; Newton, Robert; Rochford, Rosemary; Cose, Stephen
  3. Frontiers in Immunology. 2024 15: 1356635.
  1. 2.   Chimeric Fusion (F) and Attachment (G) Glycoprotein Antigen Delivery by mRNA as a Candidate Nipah Vaccine
  2. Loomis, Rebecca J.; DiPiazza, Anthony T.; Falcone, Samantha; Ruckwardt, Tracy J.; Morabito, Kaitlyn M.; Abiona, Olubukola M.; Chang, Lauren A.; Caringal, Ria T.; Presnyak, Vladimir; Narayanan, Elisabeth; Tsybovsky,Yaroslav; Nair, Deepika; Hutchinson, Geoffrey B.; Stewart-Jones, Guillaume B. E.; Kueltzo, Lisa A.; Himansu, Sunny; Mascola, John R.; Carfi, Andrea; Graham, Barney S.
  3. Frontiers in Immunology. 2021, Dec 8; 12
  1. 3.   Inhibition of the DNA damage response phosphatase PPM1D reprograms neutrophils to enhance anti-tumor immune responses
  2. Uyanik, Burhan; Goloudina, Anastasia R.; Akbarali, Aamir; Grigorash, Bogdan B.; Petukhov, Alexey V.; Singhal, Sunil; Eruslanov, Evgeniy; Chaloyard, Jeanne; Lagorgette, Lisa; Hadi, Tarik; Baidyuk, Ekaterina V.; Sakai, Hiroyasu; Tessarollo,Lino; Ryffel, Bernhard; Mazur, Sharlyn J.; Lirussi, Frederic; Garrido, Carmen; Appella, Ettore; Demidov, Oleg N.
  3. NATURE COMMUNICATIONS. 2021, Jun 15; 12(1):
  1. 4.   Modulation of MHC-E transport by viral decoy ligands is required for RhCMV/SIV vaccine efficacy
  2. Verweij, Marieke C.; Hansen, Scott G.; Iyer, Ravi; John, Nessy; Malouli, Daniel; Morrow, David; Scholz, Isabel; Womack, Jennie; Abdulhaqq, Shaheed; Gilbride, Roxanne M.; Hughes, Colette M.; Ventura, Abigail B.; Ford, Julia C.; Selseth, Andrea N.; Oswald,Kelli; Shoemaker,Rebecca; Berkemeier,Brian; Bosche,Bj; Hull,Mike; Shao, Jason; Sacha, Jonah B.; Axthelm, Michael K.; Edlefsen, Paul T.; Lifson,Jeffrey; Picker, Louis J.; Frueh, Klaus
  3. Science. 2021, Apr 30; 372(6451):
  1. 5.   Co-immunization of DNA and Protein in the Same Anatomical Sites Induces Superior Protective Immune Responses against SHIV Challenge
  2. Felber,Barbara; Lu, Zhongyan; Hu, Xintao; Valentin,Antonio; Rosati,Margherita; Remmel, Christopher A L; Weiner, Joshua A; Carpenter, Margaret C; Faircloth, Katelyn; Stanfield-Oakley, Sherry; Williams, Wilton B; Shen, Xiaoying; Tomaras, Georgia D; LaBranche, Celia C; Montefiori, David; Trinh, Hung V; Rao, Mangala; Alam, Munir S; Vandergrift, Nathan A; Saunders, Kevin O; Wang, Yunfei; Rountree, Wes; Das, Jishnu; Alter, Galit; Reed, Steven G; Aye, Pyone P; Schiro, Faith; Pahar, Bapi; Dufour, Jason P; Veazey, Ronald S; Marx, Preston A; Venzon, David J; Shaw, George M; Ferrari, Guido; Ackerman, Margaret E; Haynes, Barton F; Pavlakis,George
  3. Cell reports. 2020, May 12; 31(6): 107624.
  1. 6.   Induction of Transient Virus Replication Facilitates Antigen-Independent Isolation of SIV-Specific Monoclonal Antibodies
  2. Pedreno-Lopez, Nuria; Dang, Christine M.; Rosen, Brandon C.; Ricciardi, Michael J.; Bailey, Varian K.; Gutman, Martin J.; Gonzalez-Nieto, Lucas; Pauthner, Matthias G.; Song, Ge; Andrabi, Raiees; Weisgrau, Kim L.; Pomplun, Nicholas; Martinez-Navio, Jose M.; Fuchs, Sebastian P.; Wrammert, Jens; Rakasz, Eva G.; Lifson,Jeffrey; Martins, Mauricio A.; Burton, Dennis R.; Watkins, David; Magnani, Diogo M.
  3. Molecular therapy. Methods & clinical development. 2020, Mar 13; 16: 225-237.
  1. 7.   Vaccine protection against rectal acquisition of SIVmac239 in rhesus macaques
  2. Gonzalez-Nieto, Lucas; Castro, Isabelle M; Bischof, Georg F; Shin, Young C; Ricciardi, Michael J; Bailey, Varian K; Dang, Christine M; Pedreño-Lopez, Nuria; Magnani, Diogo M; Ejima, Keisuke; Allison, David B; Gil, Hwi Min; Evans, David T; Rakasz, Eva G; Lifson,Jeffrey; Desrosiers, Ronald C; Martins, Mauricio A
  3. PLoS pathogens. 2019, Sep 30; 15(9): e1008015.
  1. 8.   A live-attenuated RhCMV/SIV vaccine shows long-term efficacy against heterologous SIV challenge
  2. Hansen, Scott G; Marshall, Emily E; Malouli, Daniel; Ventura, Abigail B; Hughes, Colette M; Ainslie, Emily; Ford, Julia C; Morrow, David; Gilbride, Roxanne M; Bae, Jin Y; Legasse, Alfred W; Oswald,Kelli; Shoemaker,Rebecca; Berkemeier,Brian; Bosche,Bj; Hull,Mike; Womack, Jennie; Shao, Jason; Edlefsen, Paul T; Reed, Jason S; Burwitz, Ben J; Sacha, Jonah B; Axthelm, Michael K; Früh, Klaus; Lifson,Jeffrey; Picker, Louis J
  3. Science translational medicine. 2019, Jul 17; 11(501): pii: eaaw2607.
  1. 9.   Nonhuman primate models of human viral infections
  2. Estes, Jake; Wong, Scott W.; Brenchley, Jason M.
  3. NATURE REVIEWS IMMUNOLOGY. 2018, Jun; 18(6): 390-404.
  1. 10.   Case report: mechanisms of HIV elite control in two African women
  2. Moosa, Yumna; Tanko, Ramla F; Ramsuran, Veron; Singh, Ravesh; Madzivhandila, Mashudu; Yende-Zuma, Nonhlanhla; Abrahams, Melissa-Rose; Selhorst, Philippe; Gounder, Kamini; Moore, Penny L; Williamson, Carolyn; Abdool Karim, Salim S; Garrett, Nigel J; Burgers, Wendy A
  3. BMC Infectious Diseases. 2018, Jan 25; 18(1): 54.
  1. 11.   Vaccine Protection against Simian Immunodeficiency Virus in Monkeys Using Recombinant Gamma-2 Herpesvirus
  2. Bilello, J. P.; Manrique, J. M.; Shin, Y. C.; Lauer, W.; Li, W. J.; Lifson, J. D.; Mansfield, K. G.; Johnson, R. P.; Desrosiers, R. C.
  3. Journal of Virology. 2011, Dec; 85(23): 12708-12720.
  1. 12.   Enhanced Control of Pathogenic Simian Immunodeficiency Virus SIVmac239 Replication in Macaques Immunized with an Interleukin-12 Plasmid and a DNA Prime-Viral Vector Boost Vaccine Regimen
  2. Winstone, N.; Wilson, A. J.; Morrow, G.; Boggiano, C.; Chiuchiolo, M. J.; Lopez, M.; Kemelman, M.; Ginsberg, A. A.; Mullen, K.; Coleman, J. W.; Wu, C. D.; Narpala, S.; Ouellette, I.; Dean, H. J.; Lin, F.; Sardesai, N. Y.; Cassamasa, H.; McBride, D.; Felber, B. K.; Pavlakis, G. N.; Schultz, A.; Hudgens, M. G.; King, C. R.; Zamb, T. J.; Parks, C. L.; McDermott, A. B.
  3. Journal of Virology. 2011, Sep; 85(18): 9578-9587.
  1. 13.   Coordinate linkage of HIV evolution reveals regions of immunological vulnerability
  2. Dahirel, V.; Shekhar, K.; Pereyra, F.; Miura, T.; Artyomov, M.; Talsania, S.; Allen, T. M.; Altfeld, M.; Carrington, M.; Irvine, D. J.; Walker, B. D.; Chakraborty, A. K.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2011, Jul; 108(28): 11530-11535.
  1. 14.   The Nonnucleoside Reverse Transcriptase Inhibitor MIV-150 in Carrageenan Gel Prevents Rectal Transmission of Simian/Human Immunodeficiency Virus Infection in Macaques
  2. Singer, R.; Derby, N.; Rodriguez, A.; Kizima, L.; Kenney, J.; Aravantinou, M.; Chudolij, A.; Gettie, A.; Blanchard, J.; Lifson, J. D.; Piatak, M.; Fernandez-Romero, J. A.; Zydowsky, T. M.; Robbiani, M.
  3. Journal of Virology. 2011, Jun; 85(11): 5504-5512.
  1. 15.   TLR-based immune adjuvants
  2. Steinhagen, F.; Kinjo, T.; Bode, C.; Klinman, D. M.
  3. Vaccine. 2011, Apr; 29(17): 3341-3355.
  1. 16.   CpG DNA as a vaccine adjuvant
  2. Bode, C.; Zhao, G.; Steinhagen, F.; Kinjo, T.; Klinman, D. M.
  3. Expert Review of Vaccines. 2011, Apr; 10(4): 499-511.
  1. 17.   Factors Associated With Viral Rebound in HIV-1-Infected Individuals Enrolled in a Therapeutic HIV-1 gag Vaccine Trial
  2. Li, J. Z.; Brumme, Z. L.; Brumme, C. J.; Wang, H. Y.; Spritzler, J.; Robertson, M. N.; Lederman, M. M.; Carrington, M.; Walker, B. D.; Schooley, R. T.; Kuritzkes, D. R.; AIDS Clinical Trials Group (ACTG) A5197 Team
  3. Journal of Infectious Diseases. 2011, Apr; 203(7): 976-983.
  1. 18.   Spontaneous Control of HCV Is Associated With Expression of HLA-B*57 and Preservation of Targeted Epitopes
  2. Kim, A. Y.; Kuntzen, T.; Timm, J.; Nolan, B. E.; Baca, M. A.; Reyor, L. L.; Berical, A. C.; Feller, A. J.; Johnson, K. L.; Zur Wiesch, J. S.; Robbins, G. K.; Chung, R. T.; Walker, B. D.; Carrington, M.; Allen, T. M.; Lauer, G. M.
  3. Gastroenterology. 2011, Feb; 140(2): 686-U434.
  1. 19.   HLA/KIR Restraint of HIV: Surviving the Fittest
  2. Bashirova, A. A.; Thomas, R.; Carrington, M.; Paul, W. E.; Littman, D. R.; Yokoyama, W. M.
  3. Annual Review of Immunology. 2011 29: 295-317.
  1. 20.   Specific Human Leukocyte Antigen Class I and II Alleles Associated with Hepatitis C Virus Viremia
  2. Kuniholm, M. H.; Kovacs, A.; Gao, X. J.; Xue, X. N.; Marti, D.; Thio, C. L.; Peters, M. G.; Terrault, N. A.; Greenblatt, R. M.; Goedert, J. J.; Cohen, M. H.; Minkoff, H.; Gange, S. J.; Anastos, K.; Fazzari, M.; Harris, T. G.; Young, M. A.; Strickler, H. D.; Carrington, M.
  3. Hepatology. 2010, May; 51(5): 1514-1522.
  1. 21.   MHC Heterozygote Advantage in Simian Immunodeficiency Virus-Infected Mauritian Cynomolgus Macaques
  2. O'Connor, S. L.; Lhost, J. J.; Becker, E. A.; Detmer, A. M.; Johnson, R. C.; MacNair, C. E.; Wiseman, R. W.; Karl, J. A.; Greene, J. M.; Burwitz, B. J.; Bimber, B. N.; Lank, S. M.; Tuscher, J. J.; Mee, E. T.; Rose, N. J.; Desrosiers, R. C.; Hughes, A. L.; Friedrich, T. C.; Carrington, M.; O'Connor, D. H.
  3. Science Translational Medicine. 2010, Mar; 2(22): 9.
  1. 22.   Mosaic vaccines elicit CD8(+) T lymphocyte responses that confer enhanced immune coverage of diverse HIV strains in monkeys
  2. Santra, S.; Liao, H. X.; Zhang, R. J.; Muldoon, M.; Watson, S.; Fischer, W.; Theiler, J.; Szinger, J.; Balachandran, H.; Buzby, A.; Quinn, D.; Parks, R. J.; Tsao, C. Y.; Carville, A.; Mansfield, K. G.; Pavlakis, G. N.; Felber, B. K.; Haynes, B. F.; Korber, B. T.; Letvin, N. L.
  3. Nature Medicine. 2010, Mar; 16(3): 324-U122.
  1. 23.   HLA-Associated Clinical Progression Correlates with Epitope Reversion Rates in Early Human Immunodeficiency Virus Infection
  2. Duda, A.; Lee-Turner, L.; Fox, J.; Robinson, N.; Dustan, S.; Kaye, S.; Fryer, H.; Carrington, M.; McClure, M.; Mclean, A. R.; Fidler, S.; Weber, J.; Phillips, R. E.; Frater, A. J.
  3. Journal of Virology. 2009 83(3): 1228-1239.
  1. 24.   Reduced Levels of Protein Tyrosine Phosphatase CD45 Protect Mice from the Lethal Effects of Ebola Virus Infection
  2. Panchal, R. G.; Bradfute, S. B.; Peyser, B. D.; Warfield, K. L.; Ruthel, G.; Lane, D.; Kenny, T. A.; Anderson, A. O.; Raschke, W. C.; Bavari, S.
  3. Cell Host & Microbe. 2009 6(2): 162-173.
  1. 25.   DNA vaccination in rhesus macaques induces potent immune responses and decreases acute and chronic viremia after SIVmac251 challenge
  2. Rosati, M.; Bergamaschi, C.; Valentin, A.; Kulkarni, V.; Jalah, R.; Alicea, C.; Patel, V.; von Gegerfelt, A. S.; Montefiori, D. C.; Venzon, D. J.; Khan, A. S.; Draghia-Akli, R.; Van Rompay, K.; Felber, B. K.; Pavlakis, G. N.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2009 106(37): 15831-15836.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel